Skip to main content

From development to market ABL provides GMP viral vectors, contributing to the success of client’s immunotherapy innovations.

ABL, leader and pioneer in the development and manufacturing of viral vectors.

Our main activities :

  • Process development
  • Manufacturing GMP/BPF
  • Qualification Validation
  • Quality Assurance
  • Quality Control

Our products are mainly used in clinical trials conducted by our customers. ABL is now recognized worldwide for its expertise in the production of a wide variety of viral vectors.


Justine CHABROL – Responsable Communication et RSE

07 89 20 00 17  –